Delph Markets

Have a question you need priced? We’ll open a private prediction market amongst expert forecasters, and you get a live probability that updates as new information lands.

Request a market Apply as a forecaster

Biotech · FDADemo

Will [Drug X] receive FDA approval by its PDUFA date?

▲ 15 pts · 30 days

Macro · RatesDemo

Will Brazil’s central bank cut rates at its next meeting?

▼ 24 pts · 30 days

Energy · GeopoliticsDemo

Will OPEC+ announce a production cut at its next meeting?

▲ 43 pts · 30 days

YES0%

+588 cr$7,054

+501 cr$6,010

BreakingBriefing documents flag a liver safety signal

BreakingAdvisory committee votes 10–3 in favour

BreakingFDA asks for more manufacturing data

BreakingLabel negotiations reported underway

BreakingManufacturing site inspection cleared

BreakingShort-seller report questions the trial data

YES0%BUY NO 200 @ 50BUY NO 250 @ 50BUY NO 150 @ 50BUY NO 250 @ 50BUY YES 300 @ 50BUY YES 200 @ 41BUY YES 200 @ 41BUY YES 250 @ 41BUY YES 200 @ 41BUY NO 400 @ 41BUY NO 250 @ 63BUY NO 350 @ 63BUY NO 100 @ 63BUY NO 350 @ 63BUY YES 250 @ 63BUY YES 100 @ 56BUY YES 150 @ 56BUY YES 200 @ 56BUY YES 250 @ 56BUY NO 100 @ 56BUY YES 400 @ 68BUY YES 300 @ 68BUY YES 300 @ 68BUY YES 200 @ 68BUY NO 200 @ 68BUY NO 200 @ 74BUY NO 100 @ 74BUY NO 300 @ 74BUY NO 400 @ 74BUY YES 250 @ 74BUY NO 200 @ 50BUY NO 250 @ 50BUY NO 150 @ 50BUY NO 250 @ 50BUY YES 300 @ 50BUY YES 200 @ 41BUY YES 200 @ 41BUY YES 250 @ 41BUY YES 200 @ 41BUY NO 400 @ 41BUY NO 250 @ 63BUY NO 350 @ 63BUY NO 100 @ 63BUY NO 350 @ 63BUY YES 250 @ 63BUY YES 100 @ 56BUY YES 150 @ 56BUY YES 200 @ 56BUY YES 250 @ 56BUY NO 100 @ 56BUY YES 400 @ 68BUY YES 300 @ 68BUY YES 300 @ 68BUY YES 200 @ 68BUY NO 200 @ 68BUY NO 200 @ 74BUY NO 100 @ 74BUY NO 300 @ 74BUY NO 400 @ 74BUY YES 250 @ 74

Reward pool$0

New marketYour marketPrivate

Question

Closes

Reward pool

$0Paid out to experts

Fund & open marketMarket open

LiveVisible only to you

Will [Drug X] receive FDA approval by its PDUFA date?

0123456789

▼ 50 pts since open

ResolvedYESFDA approved

Payout · $25,000 pool11 of 26 traders in profit

$7,054$6,010

Each share of the pool is that trader's share of the total profit, counting gains from trading and at settlement. Traders at a loss get nothing.

We know this works

Decades of research show markets beat experts and polls.

25% lower forecast error than Ford’s in-house sales experts
Cowgill & Zitzewitz, Review of Economic Studies (2015)
73% accuracy predicting which scientific findings would replicate
Gordon et al., PLoS ONE (2021)
74% of the time markets beat polls, across 964 polls and five elections
Berg, Nelson & Rietz, Int’l Journal of Forecasting (2008)

The problem

Funds lean on a few analysts and expert calls. You get opinions that are hard to weigh, harder to quantify, and stale by the time the research is done.

01
Hard to scale, now Scalable
Any number of experts feed one market. No scheduling 50 calls to hear 50 views.
02
Unquantified, now Quantified
Trades turn scattered beliefs into a single, usable probability.
03
Unmeritocratic, now Meritocratic
You pay for accuracy, not a PhD. Better forecasters earn more and carry more weight.
04
Slow, now Fast
Workable results within hours, and a price that moves the moment new evidence lands.

Why Delph

Public markets only list questions with mass appeal, and anyone can see the price. Your edge depends on being the only one who has it.

ApproachDomain expertsPrivate edgeQuantifiedFastMeritocratic

In-house analysts only

Expert networks

Public prediction markets

AI forecasting

Delph Markets

Private Prediction Markets as a Service.

Will [Drug X] receive FDA approval by its PDUFA date?

Will Brazil’s central bank cut rates at its next meeting?

Will OPEC+ announce a production cut at its next meeting?

How it works

Expert knowledge is valuable. Turning it into a number is the hard part.

Hard to scale, now Scalable

Unquantified, now Quantified

Unmeritocratic, now Meritocratic

Slow, now Fast

The accuracy of a market. The privacy of an expert call.

Sounds cool? Stay updated.